Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenling Baizhu Tablets (参苓白术片) is a traditional Chinese medicine (TCM) marketed by Xian Zhengda Pharmaceutical. Formulated as an oral tablet, it is composed of several traditional herbs, including Codonopsis pilosula, Poria cocos, Atractylodes macrocephala, Dioscorea opposita, Semen Lablab Album, Semen Nelumbinis, Semen Coicis, Fructus Amomi, Platycodon grandiflorus, Glycyrrhiza uralensis, and Citrus reticulata. It is indicated for invigorating the spleen and replenishing qi, and is commonly used to treat symptoms such as fatigue, poor appetite, and loose stools (diarrhea) associated with spleen-qi deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenling Baizhu Tablets.